NCT01317381

Brief Summary

ICG- Leberfunktionstest versus "neue" Biomarker als prognostischer Marker bei intensivmedizischen Patienten

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 23, 2010

Completed
7 months until next milestone

First Posted

Study publicly available on registry

March 17, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

March 17, 2011

Status Verified

August 1, 2010

First QC Date

August 23, 2010

Last Update Submit

March 15, 2011

Conditions

Critically Ill Patients

Study Arms (1)

ICU patients

Admitted patients to the ICU

Procedure: Observational

Interventions

ObservationalPROCEDURE

Blood draw

ICU patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Admitted ICU Patients

You may qualify if:

  • Intensiv-Patienten mit Verbrennungen \> 10% der Körperoberfläche
  • Alter \> 18
  • Gruppe 2:
  • Intensivpatienten nach grossen chirurgischen Eingriffen
  • Alter \> 18
  • Gruppe 3:
  • Polytraumatisierte, intensivpflichtige Patienten
  • Alter \> 18

You may not qualify if:

  • Schwangerschaft
  • Einschluss in eine andere Studie
  • Moribunde Patienten
  • Patienten, die kein Deutsch verstehen
  • Jodunverträglichkeit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Zurich, Switzerland

RECRUITING

MeSH Terms

Interventions

Watchful Waiting

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Officials

  • 01 Studienregister MasterAdmins

    UniversitaetsSpital Zuerich

    STUDY DIRECTOR

Central Study Contacts

01 Studienregister MasterAdmins

CONTACT

+41 (0)44 255 11 11

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 23, 2010

First Posted

March 17, 2011

Study Start

May 1, 2010

Study Completion

May 1, 2011

Last Updated

March 17, 2011

Record last verified: 2010-08

Locations

CH(1)